when was semaglutide patented Brazilian federal court denies patent extension Looming GLP-1 drug patent expirations

What Happens: Improved insulin sensitivity Better fat metabolism Reduced inflammation Positive effects on lipid profiles Lower blood pressure Cardiovascular benefits What You Experience: More energy Better exercise tolerance Improved lab markers (cholesterol, triglycerides) Reduced risk of metabolic diseases These effects contribute to overall health improvement beyond just weight loss

The STEP (Semaglutide Treatment Effect in People with obesity) trial program showed that participants using semaglutide 2.4 mg weekly achieved an average weight loss of 12-15% of their initial body weight over 68 weeks, compared to 2-3% with placebo

Over 61% of healthcare providers prefer GLP-1 drugs due to cardiovascular risk reduction benefits, impacting nearly 32% of high-risk patients globally

Based on patient reports and clinical observations, some women may experience: Irregular cycles: Changes in cycle length, with periods occurring earlier or later than expected

A lot of people who practice intermittent fasting simply skip breakfast and stop eating after a certain time in the evening

This personalization can support more thoughtful risk-benefit discussions